Adaptive Biotechnologies Corp (ADPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 46,435 | 43,190 | 41,873 | 45,784 | 37,919 |
| Cost of Goods | 16,667 | 19,317 | 18,051 | 19,616 | 19,346 |
| Gross Profit | 29,768 | 23,873 | 23,822 | 26,168 | 18,573 |
| Operating Expenses | 63,067 | 71,508 | 72,635 | 97,852 | 69,875 |
| Operating Income | -32,632 | -47,318 | -48,762 | -71,068 | -50,956 |
| Interest Expense | 2,939 | 2,696 | 2,993 | 3,012 | 3,652 |
| Other Income | 3,474 | 3,766 | 4,222 | 4,613 | 4,282 |
| Pre-tax Income | -32,097 | -46,248 | -47,533 | -69,467 | -50,326 |
| Net Income Continuous | -32,097 | -46,248 | -47,533 | -69,467 | -50,326 |
| Minority Interests | -26 | -26 | -26 | -26 | -26 |
| Net Income | $-32,071 | $-46,222 | $-47,507 | $-69,441 | $-50,300 |
| EPS Basic Total Ops | -0.22 | -0.31 | -0.33 | -0.48 | -0.35 |
| EPS Basic Continuous Ops | -0.22 | -0.31 | -0.33 | -0.48 | -0.35 |
| EPS Diluted Total Ops | -0.22 | -0.31 | -0.33 | -0.48 | -0.35 |
| EPS Diluted Continuous Ops | -0.22 | -0.31 | -0.33 | -0.48 | -0.35 |
| EPS Diluted Before Non-Recurring Items | -0.22 | -0.26 | -0.33 | -0.30 | -0.35 |
| EBITDA(a) | $-30,049 | $-44,414 | $-46,191 | $-68,635 | $-47,891 |